TrialThe Journal of infectious diseases2025

Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA) for Preventing Recurrent Clostridioides difficile Infection.

Ken F Blount et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.